Samsung Biologics closes public tender offer for the Polypeptide Group…Over 90% of the shares submitted
From the source
Read at newsworks.co.krSamsung Biologics closes public tender offer for the Polypeptide Group…Over 90% of the shares submitted
The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.
Read at newsworks.co.krSamsung Biologics closes public tender offer for the Polypeptide Group…Over 90% of the shares submitted